Short Description:

[Indication] 

Resmetirom is indicated as an adjunct therapy, alongside diet and exercise, for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis (NASH) with moderate to advanced liver scarring (F2 to F3 fibrosis).